"The U.S. Food and Drug Administration today approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases."...
Additional Mylotarg Information
Mylotarg - User Reviews
Report Problems to the Food and Drug Administration
Find out what women really need.